Researchers have investigated Manfredokimab AK120, a novel interleukin 17A (IL-17A) inhibitor , regarding treatment option for individuals suffering from ulcerative colitis. Preliminary data suggest that this https://mediajx.com/story28397881/manfidokimab-ak120-a-promising-prospect-for-uc